lysophosphatidic acid has been researched along with morphine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, V; Elmes, SJ; Kendall, DA; Millns, PJ; Smart, D | 1 |
| Nagai, J; Ueda, H | 1 |
| Kato, A; Ogawa, K; Shinohara, S; Takasu, K; Yoneda, Y | 1 |
3 other study(ies) available for lysophosphatidic acid and morphine
| Article | Year |
|---|---|
Evidence for biological effects of exogenous LPA on rat primary afferent and spinal cord neurons.
Topics: Action Potentials; Afferent Pathways; Analysis of Variance; Animals; Autoradiography; Calcium; Dose-Response Relationship, Drug; Drug Interactions; Ganglia, Spinal; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Lysophospholipids; Male; Morphine; Narcotics; Neurons, Afferent; Pain Measurement; Potassium Chloride; Rats; Rats, Sprague-Dawley; Reaction Time; Spinal Cord; Statistics, Nonparametric; Sulfur Isotopes | 2004 |
Pre-emptive morphine treatment abolishes nerve injury-induced lysophospholipid synthesis in mass spectrometrical analysis.
Topics: Animals; Lysophosphatidylcholines; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Morphine; Sciatic Neuropathy; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Treatment Outcome | 2011 |
Pharmacological characterization of lysophosphatidic acid-induced pain with clinically relevant neuropathic pain drugs.
Topics: Amines; Analgesics; Animals; Calcium Channels; Cyclohexanecarboxylic Acids; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Ganglia, Spinal; Hyperalgesia; Indomethacin; Lysophospholipids; Male; Mice; Morphine; Motor Activity; Neuralgia; Neurons; Pregabalin; Spinal Cord | 2012 |